17q12, explained for kidsdeletion syndrome · static snapshot
Adults Scientists Kids EN NL
Everything here was found on the internet and put together with help from a computer program that reads and writes (AI). It is here so you can learn — it is not the final word. Always check the real source. Read the whole notice
A number from a study Kidneys and diabetes 1 supporting source confidence 97% novelty 60%

Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P <

A source reports “97%” in the context of kidney: “Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P < 0.001) and displayed a delayed progression to ESKF ( Supplementary Figure S3 a, P < 0.001) with ESKF-free survival of 97% (95% CI: 95-100) ”

More a number from a study

How this was derived

Numbers are quoted verbatim from the source; check the source before quoting onward.

Generated 2026-11-13, last changed yesterday. Dedup key freq:97%. The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.

Evidence (1 quote)

Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions peer_reviewed · published 2024-01-01 · live page
Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P < 0.001) and displayed a delayed progression to ESKF ( Supplementary Figure S3 a, P < 0.001) with ESKF-free survival of 97% (95% CI: 95-100) for the 17q12del versus 86% (95% CI: 79-94) for HNF1B variants at the age of 18 years.

Supporting documents (1)

StorySourcePublishedSeenRelevance
Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and... pmc 2024-01-01 yesterday 1.00